TWTorin W. Waters

Torin W. Waters

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Torin W. Waters has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemia

    by Torin W. Waters, David S. Dickens

    Background: Sedation for lumbar punctures (LPs) in pediatric acute lymphoblastic leukemia (ALL) patients has been the standard for decades to reduce pain and anxiety. Recent studies on the potential long‐term neurocognitive effects of cumulative propofol exposure have raised concerns about this practice. The recent pandemic introduced additional burdens to patients, with the requirement of a negative COVID‐19 test prior to each sedated procedure.Procedure: These factors prompted a quality improvement intervention at our institution where we aimed to reduce postinduction sedated LPs by 50%. Our intervention included patient and family education, followed by a simulation of the procedure for selected patients. Those converted to unsedated LPs were queried for their preference. Comparative cost, clinical time, and LP success rates were collected for sedated and unsedated LPs.Results: Following the intervention, the percentage of LPs performed with sedation dropped from 100% to 48%. All LPs were successful using both techniques. Most patients who experienced the unsedated LP technique, and their guardians, strongly preferred this approach. Unsedated LPs significantly reduced clinical time (169 vs. 83 minutes) for families, decreased expenditures ($5736 reduction per procedure), and improved institutional opportunity cost due to a decrease in last‐minute cancelations.Conclusion: We have shown that it is feasible to significantly reduce the use of sedation for LPs in patients with ALL, which has the potential to improve health and patient experience at a lower cost.


  • Open Access

    Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemia

    by Torin Waters, David Dickens

    Background: Sedation for lumbar punctures (LPs) in pediatric acute lymphoblastic leukemia (ALL) patients has been the standard for decades to reduce pain and anxiety. Recent studies on the potential long-term neurocognitive effects of cumulative propofol exposure has raised concerns about this practice. The recent pandemic introduced additional burdens to patients, with the requirement of a negative COVID-19 test prior to each sedated procedure. Procedure: These factors prompted a quality improvement intervention at our institution where we aimed to reduce post-Induction sedated lumbar punctures (LPs) by 50%. Our intervention included patient and family education followed by a simulation of the procedure for selected patients. Those converted to unsedated LPs were queried for their preference. Comparative cost, clinical time and LP success rates were collected for sedated and unsedated LPs. Results: Following the intervention, the percentage of LPs performed with sedation dropped from 100% to 48.1%. All LPs were successful using both techniques. Most patients who experienced the unsedated LP technique, and their guardians, strongly preferred this approach. Unsedated LPs significantly reduced clinical time (169 vs 83 minutes) for families, decreased expenditures ($5,736.16 reduction per procedure) and improved institutional opportunity cost due to a decrease in last-minute cancellations. Conclusion: We have shown that it is feasible to significantly reduce the use of sedation for LPs in patients with ALL, which has the potential to improve health and patient experience at a lower cost.

  • Refractory infantile high‐grade glioma containing TRK‐fusion responds to larotrectinib

    by Torin W. Waters, Steven A. Moore, Yutaka Sato, Brian J. Dlouhy, Mariko Sato


  • Open Access

    Refractory infantile high-grade glioma containing TRK-fusion responds to larotrectinib

    by Torin Waters, Steven Moore, Yutaka Sato, Brian Dlouhy, Mariko Sato

    High-grade gliomas (HGGs) are a challenging group of brain tumors. Identification of targetable genetic alterations such as TRK fusions are providing new treatment options. We discuss an infant who presented with hydrocephalus and a cystic mass at birth, while a solid tumor component of the mass was only appreciated later. Tumor analysis was consistent with HGG containing a TRK fusion. Despite treatment with conventional chemotherapy, his tumor progressed in size. He was started on larotrectinib and experienced a significant decrease in tumor burden. This case demonstrates that targeted therapy may be effective for a subset of TRK fusion-positive CNS tumors.